General description
INN
Abiraterone
Medicine type
Chemical agent
EML status history
First added in 2019
(TRS
1021)
for
Malignant neoplasms of prostate
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Hormones and antihormones
- Oral > Solid: 250 mg; 500 mg
Indications